Postgraduate Institute for Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. The presenting faculty reported the following:
Ann Marie Bamford, RN, MSN
Fairfax Northern Virginia Hematology/Oncology
Fairfax, Virginia
No financial interests or affiliations to disclose
Gershon Locker, MD
Kellogg Scanlon Chair of Oncology,
Evanston Northwestern Healthcare
Professor of Medicine, Northwestern University, Feinberg School of Medicine
Evanston, Illinois Grants/Research Support: AstraZeneca
Pharmaceuticals LP Consultant and Honorarium: AstraZeneca
Pharmaceuticals LP, Sanofi-Synthelabo Inc
Jean M Lynn, MPH, RN, OCN
Oncology Healthcare Consultants
Adjunct Assistant Professor,
School of Public Health and Health Policy,
George Washington University,
Washington, DC Consultant and Speakers Bureau: AstraZeneca Pharmaceuticals LP
Heather C Morgan, RN
Nurse Manager
Fairfax Northern Virginia Hematology/ Oncology
Fairfax, Virginia
No financial interests or affiliations to disclose
Mark D Pegram, MD
Associate Professor of Medicine,
David Geffen School of Medicine at UCLA
Director, Women’s Cancer Program-UCLA/Jonsson
Comprehensive Cancer Center Consultant and Honorarium: Roche Laboratories
Inc
Nicholas J Robert, MD
Chairman, Research Committee,
Cancer Center, Inova Fairfax Hospital
Chair, Breast Cancer Committee
US Oncology Research Network
Fairfax, Virginia Grants/Research Support: Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, Novartis Pharmaceuticals Honorarium: AstraZeneca Pharmaceuticals
LP, Bristol-Myers Squibb Company, Genentech BioOncology, Novartis Pharmaceuticals, Roche Laboratories Inc
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. The Postgraduate Institute for Medicine (PIM), Research To Practice, AstraZeneca Pharmaceuticals LP and Genentech BioOncology do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Research To Practice, AstraZeneca Pharmaceuticals LP or Genentech BioOncology. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.
